Global Esophageal Cancer Patient Insights and Epidemiology - 2016

  • ID: 3692140
  • Report
  • Region: Global
  • 110 pages
  • Epipatients
1 of 3
The latest survey Global Esophageal Cancer Patient Insights and Epidemiology – 2016, provides insights into total Esophageal Cancer patients on drug therapies in top 7 markets, Esophageal Cancer treatable patients, and Esophageal Cancer epidemiology in top 7 markets. Epipatients conducted an online survey with Esophageal Cancer specialists, oncologists, and Esophageal Cancer patients to identify the Esophageal Cancer patients in top 7 markets who were treated by drug therapies. The research also identifies total Esophageal Cancer patients’ on drug therapies by Esophageal Cancer stages.
Depending on the type and stage of esophageal cancer, chemotherapies may be given to patients. Also, targeted therapies were given to patients when standard chemotherapy drugs does not work. This study accurately determines and forecast Esophageal Cancer patients who were on drug therapies in a given year. This research also provides insights into Esophageal Cancer epidemiology including Esophageal Cancer incidence and Esophageal Cancer prevalence by Esophageal Cancer stages I-IV.

Key Questions Answered:
- Countries: US, Japan, Germany, France, Italy, Spain, UK
- Esophageal Cancer Incidence in top 7 markets by staging – Stage I, Stage II, Stage III, and Stage IV
- Esophageal Cancer Prevalence in top 7 markets (10-year) by staging – Stage I, Stage II, Stage III, and Stage IV
- Esophageal Cancer Treatable Patients in top 7 markets by staging – Stage I, Stage II, Stage III, and Stage IV
- Esophageal Cancer Patients on drug therapies by stages – Stage I, Stage II, Stage III, and Stage IV
- Base Year – 2015, Historic from 2010 and forecast to 2025

Key Benefits:
This research will help analysts, healthcare providers, pharmaceutical companies, epidemiologists, clinical research organizations, universities, government agencies, and insurers to determine their study population. This research will help executives estimate Esophageal Cancer market potential, Esophageal Cancer drug therapies market potential, assess unmet need, patient share, market share, develop forecasting models, and build patient-based health management frameworks. The data presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Methodology
2. Esophageal Cancer Patients Globally by Stages
2.1. Incidence
2.2. Prevalence
2.3. Treatable Patients
2.4. Patients on drug therapies
3. Esophageal Cancer Patients in Germany by Stages
3.1. Incidence
3.2. Prevalence
3.3. Treatable Patients
3.4. Patients on drug therapies
4. Esophageal Cancer Patients in France by Stages
4.1. Incidence
4.2. Prevalence
4.3. Treatable Patients
4.4. Patients on drug therapies
5. Esophageal Cancer Patients in Italy by Stages
5.1. Incidence
5.2. Prevalence
5.3. Treatable Patients
5.4. Patients on drug therapies
6. Esophageal Cancer Patients in Spain by Stages
6.1. Incidence
6.2. Prevalence
6.3. Treatable Patients
6.4. Patients on drug therapies
7. Esophageal Cancer Patients in UK by Stages
7.1. Incidence
7.2. Prevalence
7.3. Treatable Patients
7.4. Patients on drug therapies
8. Esophageal Cancer Patients in Japan by Stages
8.1. Incidence
8.2. Prevalence
8.3. Treatable Patients
8.4. Patients on drug therapies
9. Esophageal Cancer Patients in US by Stages
9.1. Incidence
9.2. Prevalence
9.3. Treatable Patients
9.4. Patients on drug therapies
10. Glossary

1. Esophageal Cancer Incidence by Stages, Global, 2010 - 2025
2. Esophageal Cancer Prevalence by Stages, Global, 2010 - 2025
3. Esophageal Cancer Treatable Patients by Stages, Global, 2010 - 2025
4. Total Esophageal Cancer Patients on drug therapies by Stages, Global, 2010 – 2025
5. Esophageal Cancer Incidence by Stages, Germany, 2010 - 2025
6. Esophageal Cancer Prevalence by Stages, Germany, 2010 - 2025
7. Esophageal Cancer Treatable Patients by Stages, Germany, 2010 - 2025
8. Total Esophageal Cancer Patients on drug therapies by Stages, Germany, 2010 - 2025
9. Esophageal Cancer Incidence by Stages, France, 2010 - 2025
10. Esophageal Cancer Prevalence by Stages, France, 2010 - 2025
11. Esophageal Cancer Treatable Patients by Stages, France, 2010 - 2025
12. Total Esophageal Cancer Patients on drug therapies by Stages, France, 2010 - 2025
13. Esophageal Cancer Incidence by Stages, Italy, 2010 - 2025
14. Esophageal Cancer Prevalence by Stages, Italy, 2010 - 2025
15. Esophageal Cancer Treatable Patients by Stages, Italy, 2010 - 2025
16. Total Esophageal Cancer Patients on drug therapies by Stages, Italy, 2010 - 2025
17. Esophageal Cancer Incidence by Stages, Spain, 2010 - 2025
18. Esophageal Cancer Prevalence by Stages, Spain, 2010 - 2025
19. Esophageal Cancer Treatable Patients by Stages, Spain, 2010 - 2025
20. Total Esophageal Cancer Patients on drug therapies by Stages, Spain, 2010 - 2025
21. Esophageal Cancer Incidence by Stages, UK, 2010 - 2025
22. Esophageal Cancer Prevalence by Stages, UK, 2010 - 2025
23. Esophageal Cancer Treatable Patients by Stages, UK, 2010 - 2025
24. Total Esophageal Cancer Patients on drug therapies by Stages, UK, 2010 – 2025
25. Esophageal Cancer Incidence by Stages, Japan, 2010 - 2025
26. Esophageal Cancer Prevalence by Stages, Japan, 2010 - 2025
27. Esophageal Cancer Treatable Patients by Stages, Japan, 2010 - 2025
28. Total Esophageal Cancer Patients on drug therapies by Stages, Japan, 2010 – 2025
29. Esophageal Cancer Incidence by Stages, US, 2010 - 2025
30. Esophageal Cancer Prevalence by Stages, US, 2010 - 2025
31. Esophageal Cancer Treatable Patients by Stages, US 2010 - 2025
32. Total Esophageal Cancer Patients on drug therapies by Stages, US, 2010 - 2025

1. Esophageal Cancer Incidence, Global, 2010 – 2025
2. Esophageal Cancer Incidence – Stage I, Global, 2010 – 2025
3. Esophageal Cancer Incidence – Stage II, Global, 2010 - 2025
4. Esophageal Cancer Incidence – Stage III, Global, 2010 - 2025
5. Esophageal Cancer Incidence – Stage IV, Global, 2010 – 2025
6. Esophageal Cancer Prevalence, Global, 2010 - 2025
7. Esophageal Cancer Prevalence – Stage I, Global, 2010 – 2025
8. Esophageal Cancer Prevalence – Stage II, Global, 2010 - 2025
9. Esophageal Cancer Prevalence – Stage III, Global, 2010 - 2025
10. Esophageal Cancer Prevalence – Stage IV, Global, 2010 - 2025
11. Esophageal Cancer Treatable Patients, Global, 2010 - 2025
12. Esophageal Cancer Treatable Patients – Stage I, Global, 2010 – 2025
13. Esophageal Cancer Treatable Patients – Stage II, Global, 2010 - 2025
14. Esophageal Cancer Treatable Patients – Stage III, Global, 2010 - 2025
15. Esophageal Cancer Treatable Patients – Stage IV, Global, 2010 - 2025
16. Esophageal Cancer Patients on drug therapies, Global, 2010 - 2025
17. Total Esophageal Cancer Patients on drug therapies – Stage I, Global, 2010 – 2025
18. Total Esophageal Cancer Patients on drug therapies – Stage II, Global, 2010 – 2025
19. Total Esophageal Cancer Patients on drug therapies – Stage III, Global, 2010 – 2025
20. Total Esophageal Cancer Patients on drug therapies – Stage IV, Global, 2010 – 2025
21. Esophageal Cancer Incidence by Stages, Germany, 2010 – 2025
22. Esophageal Cancer Prevalence by Stages, Germany, 2010 – 2025
23. Esophageal Cancer Treatable Patients by Stages, Germany, 2010 – 2025
24. Esophageal Cancer Patients on drug therapies, Germany, 2010 - 2015
25. Esophageal Cancer Incidence by Stages, France, 2010 – 2025
26. Esophageal Cancer Prevalence by Stages, France, 2010 – 2025
27. Esophageal Cancer Treatable Patients by Stages, France, 2010 – 2025
28. Esophageal Cancer Patients on drug therapies, France, 2010 – 2025
29. Esophageal Cancer Incidence by Stages, Italy, 2010 – 2025
30. Esophageal Cancer Prevalence by Stages, Italy, 2010 – 2025
31. Esophageal Cancer Treatable Patients by Stages, Italy, 2010 – 2025
32. Esophageal Cancer Patients on drug therapies, Italy, 2010 – 2025
33. Esophageal Cancer Incidence by Stages, Spain, 2010 – 2025
34. Esophageal Cancer Prevalence by Stages, Spain, 2010 – 2025
35. Esophageal Cancer Treatable Patients by Stages, Spain, 2010 – 2025
36. Esophageal Cancer Patients on drug therapies, Spain, 2010 - 2015
37. Esophageal Cancer Incidence by Stages, UK, 2010 – 2025
38. Esophageal Cancer Prevalence by Stages, UK, 2010 – 2025
39. Esophageal Cancer Treatable Patients by Stages, UK, 2010 – 2025
40. Esophageal Cancer Patients on drug therapies, UK, 2010 – 2025
41. Esophageal Cancer Incidence by Stages, Japan, 2010 – 2025
42. Esophageal Cancer Prevalence by Stages, Japan, 2010 – 2025
43. Esophageal Cancer Treatable Patients by Stages, Japan, 2010 – 2025
44. Esophageal Cancer Patients on drug therapies, Japan, 2010 – 2025
45. Esophageal Cancer Incidence by Stages, US, 2010 – 2025
46. Esophageal Cancer Prevalence by Stages, US, 2010 – 2025
47. Esophageal Cancer Treatable Patients by Stages, US, 2010 – 2025
48. Esophageal Cancer Patients on drug therapies, US, 2010 - 2015
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll